The group was reviewing a paper on tirzepatide, a GLP-1 agonist, which reported that the drugs efficacy for weight loss was nearly comparable to that of bariatric surgery
however, they are not devoid of risks: Gastrointestinal Side Effects : Nausea, bloating, and vomiting are common issues
Digestive Issues Some people may experience gastrointestinal discomfort, such as nausea, cramps, diarrhea, or bloating
doi: 10.1126/scitranslmed.aaf1059 120 SimsJRZimmerJAEvansCDLuMArdayfioPSparksJet al
Our survey asked respondents to rate their organizations view regarding coverage of obesity medications on a scale from 1 ( lifestyle condition should not cover ) to 10 ( chronic condition to treat should cover )
7-Day Support: Customer support via email, phone, or text seven days a week